Get your first tease of gameplay from Alkahest, a new first-person medieval fantasy action-adventure RPG from developer Push On that bills itself as a spiritual successor to Dark Messiah of Might ...

Alkahest is a new first-person fantasy action-adventure RPG from developer Push On that bills itself as a spiritual successor to Dark Messiah of Might & Magic while also citing Dishonored and ...

--Alkahest, Inc., a clinical stage biotechnology company focused on discovering and developing transformative therapies to treat age-related diseases and a subsidiary of Grifols, today announced ...

Will Alkahest's combat system be just as fun to play as it is to watch from the trailers? We'll have to wait to find out when Alkahest eventually launches on Xbox Series X | S, PlayStation 5, and ...

"Alkahest is an action-adventure RPG set in a murky medieval world, where satisfying melee combat with highly interactive environments takes center stage," the newly-revealed Steam page says.

- Grifols to acquire remaining stock of Alkahest, Inc. in exchange for a total price of $146 million, on a debt-free basis, bringing its ownership of Alkahest to 100%; the transaction is expected ...

On top of my sense that the trailer is indeed gameplay, Alkahest has a publisher now—HypeTrain Digital—whose other signed games include Voidtrain, Breathedge, and the upcoming Pathologic 3.

SAN CARLOS, Calif., July 09, 2020 -- Alkahest, Inc., a clinical stage biotechnology company focused on discovering and developing transformative therapies to treat age-related.

Alkahest is located in San Carlos. Scientists there are working on innovative therapies for diseases that are linked to aging which include Alzheimer's disease, Parkinson's disease and age-related ...

Alkahest founder and Stanford University professor Tony Wyss-Coray. Norbert von der Groeben/Stanford School of Medicine.

SAN CARLOS, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical stage biotechnology company focused on discovering and developing transformative therapies to treat age-related ...